DelveInsight has launched a new report on “Epithelial Ovarian Cancer – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Epithelial Ovarian Cancer – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Epithelial Ovarian Cancer, historical and forecasted epidemiology as well as the Epithelial Ovarian Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Epithelial Ovarian Cancer Market Report:
- The American Cancer Society estimates for ovarian cancer in the United States for 2020 are:
- About 21,750 women will receive a new diagnosis of ovarian cancer.
- About 13,940 women will die from ovarian cancer
Key benefits of the report:
- Epithelial Ovarian Cancer market report covers a descriptive overview and comprehensive insight of the Epithelial Ovarian Cancer Epidemiology and Epithelial Ovarian Cancer market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Epithelial Ovarian Cancer market report provides insights on the current and emerging therapies.
- Epithelial Ovarian Cancer market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Epithelial Ovarian Cancer market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Epithelial Ovarian Cancer market.
Epithelial Ovarian Cancer Overview
Ovarian cancer is a group of diseases that originates in the ovaries, or in the related areas of the fallopian tubes and the peritoneum. It is one of the most common gynecologic cancers, and one of the leading causes of cancer-associated female mortality in the world. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumour. In about 90 per cent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60. Epithelial ovarian tumours develop from the cells that cover the outer surface of the ovary. Most epithelial ovarian tumours are benign. There are several types of benign epithelial tumours, including serous adenomas, mucinous adenomas, and Brenner tumours. Cancerous epithelial tumours are carcinomas – meaning they begin in the tissue that lines the ovaries.
Epithelial Ovarian Cancer Market
The dynamics of the Epithelial Ovarian Cancer market is anticipated to change in the coming years owing to the expected launch of emerging therapies such as Immunogen, Celsion Corporation, OncoQuest, Roche, PRGN-3005 UltraCAR-T, Ellipses Pharma, and others during the forecasted period 2018-2030.
Epithelial Ovarian Cancer Pipeline Therapies and Key Companies
- Mirvetuximab: Immunogen
- GEN-1: Celsion Corporation
- Oregovomab: OncoQuest
- Tecentriq: Roche
- Precigen: PRGN-3005 UltraCAR-T
- EP0057: Ellipses Pharma
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Epithelial Ovarian Cancer Patient Share (%) Overview at a Glance
5. Epithelial Ovarian Cancer Market Overview at a Glance
6. Epithelial Ovarian Cancer Disease Background and Overview
7. Epithelial Ovarian Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Epithelial Ovarian Cancer
9. Epithelial Ovarian Cancer Current Treatment and Medical Practices
10. Unmet Needs
11. Epithelial Ovarian Cancer Emerging Therapies
12. Epithelial Ovarian Cancer Market Outlook
13. Country-Wise Epithelial Ovarian Cancer Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Epithelial Ovarian Cancer Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
“Epithelial Ovarian Cancer Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Epithelial Ovarian Cancer market. A detailed picture of the Epithelial Ovarian Cancer pipeline landscape is provided, which includes the disease overview and Epithelial Ovarian Cancer treatment guidelines.
DelveInsight’s ‘Epithelial Ovarian Cancer Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Epithelial Ovarian Cancer epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States